Phone: (707) 546-5553
Email Us
1140 Sonoma Avenue 1-A
Santa Rosa, CA 95405

HIFU

HIFU Prostate Services Expands Management Team with Chief Operating Officer

John McLean brings significant amount of experience in HIFU, operations, marketing and medical imaging. CHARLOTTE, N.C. March 9, 2016. HIFU Prostate Services, LLC, a leading provider of minimally invasive prostate cancer treatments using high intensity focused ultrasound (“HIFU”), is pleased to announce the addition of John McLean as chief operating officer. McLean brings 17 years [...]

March 29th, 2016|

Prostate cancer targeted with ultrasound ‘could transform treatment’

The study - on the effectiveness of high-intensity focused ultrasound (HIFU) to treat men with localized prostate cancer - featured at the European Association of Urology Congress (EAU16) in Munich, Germany, March 11-15, 2016. Led by University College Hospital (UCH) in London, UK, the study followed 625 men between 2004-2015, who were treated in the [...]

March 29th, 2016|

HIFU: Prostate Cancer Treatment Has 97% Survival Rate

A prostate cancer treatment which is rarely offered on the NHS may give patients a 97% chance of survival after five years, a landmark study has suggested. The so-called “male lumpectomy” treatment works by treating just the prostate cancer tumor with High Intensity Focused Ultrasound (HIFU). It is said to have “significantly fewer side effects” [...]

March 24th, 2016|

HIFU: Taking the UK By Storm

A treatment that uses sound waves to blast away prostate tumors has been proven to cure as many men of the disease as that of the surgery that removes the gland – while causing significantly fewer side effects. Until now the new procedure, called high-intensity focused ultrasound (HIFU), has been considered experimental. This has meant [...]

March 15th, 2016|

Study Supports Hemiablation HIFU for Prostate Cancer

Story source: Renal & Urology News. Jody A. Charnow, Editor. February 10, 2016 High-intensity focused ultrasound (HIFU) hemiablation offers mid-term promising functional and oncologic outcomes in carefully selected patients with clinically localized prostate cancer (PCa), according to researchers. In a prospective cohort study of 50 patients who underwent HIFU ablation of a single lobe of the prostate, [...]

February 25th, 2016|

The Press Democrat: Santa Rosa doctor one of few using new treatment for prostate cancer

by Martin Espinoza | The Press Democrat | December 3, 2015 Santa Rosa urologist Michael Lazar has been traveling to Puerto Vallarta since 2007, though not exactly for sun and fun. Lazar is part of a vanguard of urologists who are treating prostate cancer with a newly approved procedure in the United States that uses [...]

December 7th, 2015|

First Prostate Cancer Patient Treated with Minimally Invasive HIFU on West Coast

Dr. Michael Lazar performing first HIFU surgery on the West Coast at San Francisco Surgery Center November 18, 2015. San Francisco, CA – HIFU Prostate Services, LLC, a leading provider of minimally- invasive prostate cancer treatment, using High Intensity Focused Ultrasound (HIFU), announced that physician partner and Medical Director, Michael J. Lazar, MD [...]

November 18th, 2015|

Minimally Invasive Prostate Cancer Treatment HIFU Now Available in the U.S.

After much anticipation the FDA has finally approved for market in the United States the Sonablate® for the ablation of prostate tissue. Sonablate® is the first High Intensity Therapeutic Ultrasound (HITU) device to receive FDA regulatory authorization for prostate tissue ablation. HIFU offers an effective treatment for localized prostate cancer with significantly less risk of [...]

November 12th, 2015|

HIFU Prostate Services Names Michael J. Lazar, MD Medical Director

Nov. 4, 2015 -- HIFU Prostate Services (HPS) has named Dr. Michael Lazar as HPS Medical Director. As HPS Medical Director Dr. Lazar will provide medical guidance and proctoring to new physicians that are being trained on the Sonablate® HIFU system in surgery centers around the country. HIFU offers an effective treatment for localized prostate [...]

November 11th, 2015|

HIFU Now Available In the U.S. Ending a Long Awaited FDA Approval Process

After much anticipation the FDA has finally approved for market in the United States the Sonablate® for the ablation of prostate tissue. Sonablate® is the first High Intensity Therapeutic Ultrasound (HITU) device to receive FDA regulatory authorization for prostate tissue ablation. HIFU offers an effective treatment for localized prostate cancer with significantly less risk of [...]

November 10th, 2015|